Federica Guglielmi | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Federica Guglielmi
Affiliation Catholic University of Sacred Heart
Country Italy
Scopus ID 57203429488
Documents 21
Citations 276
h-index 10
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0000-0002-1812-0479

Federica Guglielmi
Catholic University of Sacred Heart,Italy

Federica Guglielmi is an Italian researcher whose scholarly activities focus on pediatric dentistry, orthodontics, craniofacial development, sleep-disordered breathing, and multidisciplinary clinical management. Her research integrates evidence-based dentistry with sleep medicine to improve diagnosis and treatment planning for pediatric patients presenting with complex developmental and genetic conditions. Through peer-reviewed publications and collaborative clinical investigations, she has contributed to the understanding of orthodontic interventions, obstructive sleep apnea risk, and rare syndromic disorders. Her publication record, citation profile, and sustained academic engagement demonstrate meaningful contributions to contemporary medicine and health sciences.[1]

Abstract

This article summarizes the academic profile of Federica Guglielmi in relation to the Best Researcher Award. Her work emphasizes translational clinical research in orthodontics, pediatric oral health, and sleep-disordered breathing. Recent publications demonstrate the application of multidisciplinary diagnostic strategies for rare genetic syndromes, dental anomalies, and obstructive sleep apnea risk in children. The combination of clinical case reporting, retrospective analyses, and collaborative research reflects a commitment to improving patient-centered healthcare while advancing scientific knowledge.[2]

Keywords

Orthodontics, Pediatric Dentistry, Sleep-Disordered Breathing, Obstructive Sleep Apnea, Craniofacial Development, Rare Diseases, Clinical Research, Medicine and Health Sciences.

Introduction

Modern orthodontic research increasingly incorporates interdisciplinary approaches that combine dental science, genetics, sleep medicine, and pediatric healthcare. Federica Guglielmi’s publications illustrate this evolving perspective by addressing complex clinical conditions requiring integrated assessment and individualized therapeutic planning. Her investigations contribute to improved diagnostic accuracy and evidence-informed management of patients with developmental anomalies and sleep-related disorders.[3]

Research Profile

According to the provided scholarly metrics, the researcher has authored 21 indexed publications with 276 citations and an h-index of 10. Her research portfolio includes case reports, retrospective clinical investigations, and collaborative studies focusing on orthodontic treatment outcomes, pediatric sleep-disordered breathing, and oral manifestations associated with rare syndromes. These indicators demonstrate sustained scientific productivity and interdisciplinary collaboration within medicine and health sciences.[1]

Research Contributions

  • Advanced multidisciplinary evaluation of pediatric sleep-disordered breathing.
  • Published clinical reports involving Gorlin–Goltz syndrome, Cantù syndrome, and Infantile Refsum disease.
  • Investigated orthodontic treatment accuracy using different attachment designs.
  • Contributed to research on obstructive sleep apnea risk and bruxism in children with autism spectrum disorders.

Publications

  • Multidisciplinary Orthodontic and Home Sleep Apnea Testing-Based Assessment of Sleep-Disordered Breathing in a Pediatric Patient with Gorlin–Goltz Syndrome.
  • Cantù Syndrome: A Case Report With Orthodontic and Sleep Disorder Findings.
  • Prevalence of OSA Risk and Bruxism in Children With Autism Spectrum Disorders.
  • The Accuracy of Maxillary Canines’ Rotation with Different Attachment Designs.

Research Impact

The research outputs have strengthened clinical understanding of pediatric orthodontics and sleep medicine by integrating dental diagnostics with multidisciplinary healthcare. Citation indicators and collaborative publications suggest that the work has gained recognition within specialized research communities while supporting improved clinical decision-making and evidence-based patient management.[4]

Award Suitability

Federica Guglielmi’s scholarly achievements align with the objectives of the Best Researcher Award by demonstrating sustained publication activity, measurable citation impact, interdisciplinary collaboration, and clinically relevant scientific contributions. Her work promotes innovation in pediatric oral healthcare and strengthens knowledge translation between orthodontics, sleep medicine, and multidisciplinary clinical practice.[5]

Conclusion

The academic record presented here reflects a researcher actively contributing to medicine and health sciences through clinically relevant, collaborative, and evidence-based investigations. Continued research in pediatric orthodontics and sleep-disordered breathing is expected to further support advances in patient care, making this profile an appropriate example of scholarly excellence recognized through academic award programs.

References

  1. Elsevier. Scopus Author Details: Federica Guglielmi, Author ID 57203429488.
    https://www.scopus.com/authid/detail.uri?authorId=57203429488
  2. Guglielmi F., et al. Multidisciplinary Orthodontic and Home Sleep Apnea Testing-Based Assessment of Sleep-Disordered Breathing. Oral (2026). DOI:
    https://doi.org/10.3390/oral6040078
  3. Guglielmi F., et al. Cantù Syndrome: A Case Report With Orthodontic and Sleep Disorder Findings. Clinical Case Reports (2026).
    https://doi.org/10.1002/ccr3.72231
  4. Alessandri-Bonetti A., et al. Prevalence of OSA Risk and Bruxism in Children With Autism Spectrum Disorders. Autism Research (2026).
    https://doi.org/10.1002/aur.70149
  5. Staderini E., et al. The Accuracy of Maxillary Canines’ Rotation with Different Attachment Designs. Journal of Clinical Medicine (2026).
    https://doi.org/10.3390/jcm15020632

Bosco Paes | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Bosco Paes
Affiliation McMaster University
Country Canada
Scopus ID 35460184000
Documents 232
Citations 8,787
h-index 46
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards

Bosco Paes
McMaster University, Canada

Bosco Paes is a Canadian physician-scientist and academic whose research has significantly contributed to neonatal medicine, respiratory syncytial virus (RSV) prevention, neonatal infectious diseases, and evidence-based pediatric healthcare. His scholarly record demonstrates sustained contributions through multicenter clinical studies, systematic reviews, health economic analyses, and international collaborations. With an extensive publication portfolio, substantial citation impact, and an h-index reflecting consistent scientific influence, his research continues to support advances in neonatal clinical practice and healthcare policy.[1]

Abstract

The academic achievements of Bosco Paes demonstrate sustained excellence in pediatric and neonatal medicine, particularly in the prevention and management of respiratory syncytial virus infections among vulnerable infant populations. His investigations integrate clinical medicine, systematic evidence synthesis, and health economics to improve patient outcomes and healthcare resource utilization. Through collaborations with international experts, his publications have influenced preventive strategies and contributed to the scientific understanding of RSV prophylaxis, neonatal intensive care, and pediatric infectious diseases.[2]

Keywords

Neonatology, Pediatrics, Respiratory Syncytial Virus, RSV Prophylaxis, Palivizumab, Nirsevimab, Neonatal Medicine, Health Economics, Systematic Review, Evidence-Based Medicine.

Introduction

Research in neonatal healthcare requires multidisciplinary collaboration and rigorous evaluation of preventive interventions. Bosco Paes has contributed extensively to this field by combining clinical expertise with population-based research and economic evaluations. His work addresses clinically important issues affecting premature infants and supports informed healthcare decisions through robust scientific evidence.[3]

Research Profile

Bosco Paes has authored more than 230 indexed scholarly documents and accumulated nearly nine thousand citations according to Scopus metrics. His research spans neonatal intensive care, pediatric infectious diseases, RSV immunoprophylaxis, epidemiology, health services research, and evidence synthesis. The consistency of his scientific productivity demonstrates long-term engagement in internationally recognized clinical research programs.[1]

Research Contributions

His recent scholarly work includes evaluations of risk factor-guided RSV prophylaxis in Colombian preterm infants, comparative meta-analyses assessing palivizumab and nirsevimab effectiveness, and expert consensus recommendations through the ARMADA Taskforce. These studies integrate clinical evidence with economic analyses and international consensus to improve preventive pediatric healthcare.[4]

Publications

  • Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants. Cost Effectiveness and Resource Allocation, 2026.
  • Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants. Human Vaccines & Immunotherapeutics, 2026.
  • Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA Taskforce, 2026.

Research Impact

The research output of Bosco Paes has informed neonatal clinical practice, preventive immunization strategies, and evidence-based healthcare policies internationally. His collaborations with clinicians, epidemiologists, and health economists have strengthened the translation of scientific findings into practical recommendations for high-risk infant populations. The citation record and publication consistency indicate substantial scholarly influence within pediatric medicine.[5]

Award Suitability

Bosco Paes demonstrates the characteristics commonly associated with distinguished research recognition through sustained scholarly productivity, international collaborations, measurable citation impact, and contributions to neonatal healthcare. His work exemplifies rigorous clinical investigation, interdisciplinary cooperation, and the practical application of scientific evidence for improving patient care, making him a suitable candidate for consideration under the Best Researcher Award category.[6]

Conclusion

The academic profile of Bosco Paes reflects sustained excellence in pediatric and neonatal research with particular emphasis on respiratory syncytial virus prevention and neonatal healthcare. His publication record, collaborative research activities, and measurable scientific impact illustrate meaningful contributions to medical science and evidence-based clinical practice. Collectively, these achievements support recognition within international academic award programs dedicated to research excellence.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Bosco Paes, Author ID 35460184000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35460184000
  2. Rodríguez-Martínez CE, Ordóñez JE, Carbonell-Estrany X, Tarride JE, Paes BA. (2026). Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants.
    https://doi.org/10.1186/s12962-026-00001-0
  3. Fullarton JR, Paes BA, Waghorne N, et al. (2026). Meta-analysis of the efficacy of palivizumab versus nirsevimab.
  4. Manzoni P, Baraldi E, Midulla F, et al. (2026). ARMADA Taskforce Systematic Review and Expert Consensus on RSV Prevention.
  5. Computer Scientists Awards. Best Researcher Award evaluation framework.
    https://computerscientists.net/

Janaina Lemos | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Janaina Lemos
Federal University of Minas Gerais,Brazil

  Janaina Lemos
Affiliation Federal University of Minas Gerais
Country Brazil
Scopus ID 50262115100
Documents 12
Citations 115
h-index 6
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards

Janaina Lemos is a Brazilian researcher whose scholarly profile reflects sustained contributions to medicine and health sciences. Her research record, indexed through Scopus Author ID 50262115100, demonstrates engagement in biomedical and clinical investigations with measurable scholarly impact. The combination of peer-reviewed publications, citation performance, and interdisciplinary collaborations illustrates an active participation in advancing scientific knowledge within health-related disciplines.[1]

Abstract

This article presents an academic overview of Janaina Lemos and her research achievements within the field of medicine and health sciences. Drawing upon bibliometric indicators and published scientific outputs, the profile highlights her contributions to biomedical research, collaborative scholarship, and evidence-based scientific advancement. The analysis also considers her suitability for recognition through the Best Researcher Award presented by the Computer Scientists Awards program.[1]

Keywords

Medicine, Health Sciences, Biomedical Research, Osteoarthritis, Scientific Publications, Citation Impact, Academic Recognition, Research Excellence.

Introduction

Academic excellence is frequently assessed through research productivity, citation influence, and contributions to scientific progress. Janaina Lemos has established a documented scholarly presence through peer-reviewed publications and collaborative investigations focused on medical and health-related challenges. Her work contributes to the broader understanding of disease mechanisms, therapeutic interventions, and healthcare outcomes.[2]

Research Profile

According to indexed bibliometric records, Janaina Lemos has authored 12 scholarly documents that have collectively received 115 citations, resulting in an h-index of 6. These indicators suggest consistent engagement with topics relevant to medicine and health sciences and demonstrate the visibility of her work within the scientific community.[1]

Research Contributions

Her research contributions include participation in studies addressing musculoskeletal disorders, therapeutic interventions, and translational health science applications. Notably, published investigations involving osteoarthritis models have explored innovative treatment strategies and biological mechanisms associated with tissue protection and disease management.[3]

Publications

  • Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis (2021).[3]
  • Additional collaborative studies addressing biomedical and clinical research themes indexed within Scopus.[1]

Research Impact

The citation performance associated with Janaina Lemos’s publications indicates that her research has been referenced by a broad range of scholarly works. Citation activity from more than one hundred citing documents reflects ongoing academic engagement with her findings and supports the relevance of her contributions within contemporary biomedical research.[1]

Award Suitability

The Best Researcher Award recognizes individuals who demonstrate measurable scholarly impact, publication quality, and sustained commitment to scientific advancement. Based on available bibliometric indicators, publication record, and research influence, Janaina Lemos demonstrates characteristics consistent with the objectives of academic recognition programs dedicated to research excellence and knowledge dissemination.[4]

Conclusion

Janaina Lemos maintains a documented research profile characterized by peer-reviewed publications, interdisciplinary collaboration, and measurable citation impact. Her scholarly activities contribute to ongoing developments in medicine and health sciences, supporting her recognition as a researcher whose work continues to inform scientific understanding and healthcare research.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Janaina Lemos, Author ID 50262115100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=50262115100
  2. Scopus Database. (n.d.). Research metrics and publication records in health sciences.
  3. Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis(2021)
    https://www.sciencedirect.com/science/article/pii/S240584402100863X
  4. Computer Scientists Awards. (n.d.). Best Researcher Award evaluation criteria.
    https://computerscientists.net/
  5. Janaina Lemos Journal. (2021). Biomedical and translational research publication record.

Anna Iwan | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Dr. Anna Iwan | Medicine | Research Excellence Award

University Clinical Hospital No.4 | Poland

Dr. Anna Iwan is a dedicated clinical oncology and internal medicine specialist with a strong focus on patient-centered cancer care, emergency medicine, and interdisciplinary clinical practice. Her professional work reflects continuous advancement in oncology treatment approaches, particularly in gynecological oncology and radiotherapy, combined with a commitment to improving patient outcomes through compassionate care and effective communication. She demonstrates strong teamwork, clinical decision-making, and empathetic patient management. Although primarily focused on clinical practice, her research visibility across Scopus and Google Scholar remains limited, with minimal indexed publications, resulting in currently low citation counts, document records, and an emerging h-index, indicating potential for future academic and research contributions.

View ORCID Profile

Featured Publications

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Assistant Professor | University of Cagliari | Italy

Assist. Prof. Dr. Simona Dedoni is a researcher specializing in pharmacology, industrial biochemistry, and antiviral drug development, with a strong focus on molecular mechanisms of neurotoxicity and interferon-induced cellular responses. Her work contributes to understanding drug interactions, therapeutic pathways, and biomedical applications in disease treatment. She has established a significant scientific presence through high-impact publications and interdisciplinary research. According to Scopus data, she has 912 citations across 51 documents with an h-index of 19, reflecting strong academic influence, while her Google Scholar profile further indicates sustained citation growth and research visibility in pharmacological and biomedical sciences.

Citation Metrics

1000

800

600

400

200

0

 

Citations
912

Documents
51

h-index
19

                               ■ Citations
■ Documents
■ h-index


View Scopus Profile View ORCID Profile

Featured Publications

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Laura Umfleet | Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Laura Umfleet | Health Sciences | Best Researcher Award

Associate Professor at Medical College of Wisconsin, United States

Dr. Laura Glass Umfleet, Psy.D., ABPP (CN), is an accomplished clinical neuropsychologist and Associate Professor of Neurology at the Medical College of Wisconsin. With expertise in adult cognitive disorders, especially neurodegeneration and congenital conditions, she is nationally certified by the American Board of Professional Psychology. Dr. Glass Umfleet serves as an editorial board member and an international leader in data-sharing initiatives. Her contributions span clinical practice, academic mentorship, and scientific collaboration, reinforcing her commitment to advancing neuropsychology through research, education, and open science initiatives. 🌍🧠📚

Publication Profile

Scopus

Academic background

Dr. Glass Umfleet earned her B.S. in Psychology with a Biology minor in 2006 and an M.S. in Psychology in 2008 from the University of Central Missouri. She completed her Psy.D. in Clinical Psychology from Roosevelt University, Chicago, in 2012 with APA accreditation. Her predoctoral internship at the University of Florida focused on neuropsychology, followed by a postdoctoral fellowship in Clinical Neuropsychology at the Medical College of Wisconsin and the Clement J. Zablocki VA Medical Center. Her educational journey reflects a strong foundation in clinical and cognitive neuroscience. 🎓📖🧬

Professional Experience

Since 2014, Dr. Glass Umfleet has served at the Medical College of Wisconsin as a Clinical Neuropsychologist, advancing to Associate Professor in 2021. She is also an Adjunct Assistant Professor at the University of Wisconsin-Milwaukee. Her clinical, academic, and leadership roles reflect her deep involvement in patient care, teaching, and research. Her professional path includes national and international presentations, peer-reviewed workshops, and active roles in neuropsychology organizations, positioning her as a respected expert in her field. 🏥📊👩‍🏫

Awards and Honors

Dr. Glass Umfleet’s professional recognition includes board certification in Clinical Neuropsychology by ABPP and editorial positions, such as Associate Editor for the Journal of Alzheimer’s Disease. She has been selected for numerous leadership roles in international neuropsychology societies, including chairing the INS WINDS SIG and serving on committees focused on student mentorship and open science. Her involvement in editorial reviews and scientific programs reflects high standing and trust in her scholarly expertise. 🏅🧠🌟

Research Focus

Dr. Glass Umfleet’s research focuses on cognitive functioning in aging and neurological conditions, including Alzheimer’s disease and adult congenital heart disease. She explores digital neuropsychological assessment, cognitive subtypes, and psychometric methods through collaborative networks like the National Neuropsychology Network. As Chair of INS WINDS, she champions data sharing and precision neuropsychology. Her work bridges clinical insight and innovative methodologies, promoting open science and advancing the field’s understanding of brain-behavior relationships. 🧪🧩💻

Publication Top Notes

🧠 Changes in cerebrovascular reactivity within functional networks in older adults with long-COVID

Year: 2025 | 🧬🧓🦠🧠 Frontiers in Neurology

🧪 Computerized adaptive test strategies for the matrix reasoning subtest of the Wechsler Adult Intelligence Scale, 4th Edition (WAIS-IV)

Year: 2024 | Cited by: 1 | 📊🧠📈📘 Journal of the International Neuropsychological Society

Conclusion

Dr. Laura Glass Umfleet is an exemplary clinical neuropsychologist whose sustained research productivity, innovative methodologies, and impactful publications over nearly two decades underscore her status as a leading figure in the field. Her national and international influence is evident through her leadership roles in global initiatives like the WINDS SIG and ACHD/Neuro Working Group, as well as frequent invited presentations at top-tier conferences. Board-certified by the ABPP and serving as Associate Professor at the Medical College of Wisconsin, Dr. Umfleet pairs academic excellence with clinical relevance. Her dedication to mentoring, editorial service, and advancing open science in neuropsychology further cements her as a highly deserving recipient of a Best Researcher Award.

 

Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Published on by Computer Scientists Awards

Prof Dr. Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Catedrática de Universidad, Universitat de Valencia, Spain

👩‍🔬 Maria A. Aguilar (also known as Maria Asunción Aguilar) is a Full Professor at the University of Valencia in the Department of Psychobiology. With a research focus on psychopharmacology and physiological psychology, she has made significant contributions to understanding the brain mechanisms underlying addiction and stress resilience. Since November 2017, she has held the prestigious position of Catedrático at the University of Valencia.

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Research in Psychobiology: María A. Aguilar is a full professor of Psychobiology at the University of Valencia, focusing on neuropsychopharmacology and physiological psychology. Her work on the interaction between social stress, drug addiction, and brain function, particularly in the context of cocaine and MDMA, contributes valuable insights to women’s health and psychology, making her a strong contender.
  2. Prolific Publication Record: With 122 published works, Aguilar’s research covers cutting-edge topics such as the role of social stress in drug addiction and the therapeutic effects of substances like cannabidiol. These areas have significant implications for mental health treatments, relevant to women’s health challenges.
  3. Leadership and Experience: She has held prominent academic roles, including being a full professor since 2017 and previously a tenured professor since 2002. Her leadership in academic settings and sustained research output strengthens her profile for the award.
  4. Innovative Contributions to Neuroscience: Aguilar’s studies on glutamatergic receptors and their role in the brain’s response to social defeat and drug addiction present novel approaches to understanding mental health disorders, making her a thought leader in neuroscience.

Areas for Improvement:

  1. Specific Focus on Women’s Health: Although her research addresses critical aspects of mental health, especially addiction and stress, a more direct focus on gender-specific issues in psychopharmacology, such as how these conditions uniquely impact women, could make her case stronger for an award dedicated to women’s research.
  2. Outreach and Public Engagement: While her academic contributions are significant, further involvement in public health initiatives or policy impact related to women’s mental health might enhance her candidacy. Increasing visibility in terms of applying her research to real-world settings could further strengthen her application.

Education

🎓 Maria A. Aguilar completed her specialization in Psychopharmacology and Physiological Psychology, with a focus on understanding the neural circuits involved in addiction and behavior. Her doctoral thesis was supervised by renowned experts Jose Miñarro and Vicente Simón.

Experience

💼 Maria A. Aguilar has had a distinguished academic career, starting as a Professor Titular at the University of Valencia in 2002 and later being promoted to Full Professor in 2017. Her teaching and research primarily focus on psychobiology, particularly studying addiction, drug abuse, and neuroplasticity.

Research Focus

🔬 Her research explores the neurobiological mechanisms of addiction and stress, especially focusing on drug-seeking behavior, neuroplasticity, and the role of glutamatergic receptors. She has conducted extensive studies on the effects of cocaine, MDMA, and cannabidiol on the brain’s reward systems.

Awards and Honors

🏅 Professor Aguilar has received various accolades throughout her career, including recognition for her groundbreaking research in psychopharmacology and neurobiology. She is a member of several professional organizations and continues to contribute to advancing the understanding of brain mechanisms in behavior.

Publication Top Notes

📝 Top Publications:

Inhibition of Nitric Oxide Synthesis Prevents the Effects of Intermittent Social Defeat on Cocaine-Induced Conditioned Place Preference in Male Mice (2024). Published in Pharmaceuticals DOI: 10.3390/ph17091203. Cited by: 6 articles.

Intermittent voluntary wheel running promotes resilience to the negative consequences of repeated social defeat in mice (2022). Published in Physiology & Behavior DOI: 10.1016/j.physbeh.2022.113916. Cited by: 12 articles.

Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice (2021). Published in Journal of Psychopharmacology DOI: 10.1177/0269881120965952. Cited by: 20 articles.

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice (2019). Published in European Journal of Neuroscience DOI: 10.1111/ejn.14190. Cited by: 15 articles.

Conclusion:

María A. Aguilar is a highly suitable candidate for the Research for Women Award due to her extensive contributions to psychobiology, particularly in the study of drug addiction and stress-related behaviors. Her long academic career, leadership roles, and prolific publication record highlight her dedication to advancing research in neuroscience. To increase her chances of winning, focusing more on the gender-specific implications of her work and enhancing public outreach could further align her profile with the award’s goals.

Sandhya Panch | Health Sciences | Women Researcher Award

Published on by Computer Scientists Awards

Dr. Sandhya Panch | Health Sciences | Women Researcher Award

Associate Professor, University of Washington, United States

Dr. Sandhya R. Panch, MD, MPH, is an esteemed Associate Professor of Medicine at the University of Washington and the Medical Director of Transfusion at the Fred Hutchinson Cancer Center. With a rich background in hematology and transfusion medicine, Dr. Panch has significantly contributed to both academic and clinical fields. Her extensive experience includes roles at the National Institutes of Health and various prestigious institutions, making her a leading expert in her specialty.

Profile

Strengths for the Award

  1. Extensive Research Contributions: Dr. Sandhya R. Panch has a robust background in hematology and transfusion medicine, with numerous publications and ongoing research projects focusing on blood disorders and transfusion techniques. Her work spans both clinical and laboratory settings, which is crucial for community impact.
  2. Leadership and Academic Roles: She holds significant positions, such as Associate Professor of Medicine at the University of Washington and Medical Director at the Fred Hutchinson Cancer Center, demonstrating her leadership and commitment to advancing medical knowledge and practice.
  3. Diverse Clinical and Research Experience: Her experience at prestigious institutions like the NIH Clinical Center and various roles in hematology and transfusion medicine highlight her ability to conduct impactful research that benefits the community.
  4. Grant and Funding Success: Dr. Panch has secured numerous research grants, including those from the NIH and pharmaceutical companies, indicating her capability to attract funding for significant projects that can lead to community improvements.
  5. Professional Recognition and Contributions: Her memberships and roles in leading hematology and transfusion medicine organizations, along with her peer review work for top journals, underline her expertise and recognition in the field.

Areas for Improvement

  1. Broader Community Engagement: While her research is highly specialized and impactful within the medical community, expanding outreach and direct engagement with broader community health initiatives could further demonstrate her commitment to community impact.
  2. Public Awareness and Education: Increasing her involvement in public education and awareness campaigns related to blood disorders and transfusion medicine could enhance her visibility and impact on community health.
  3. Interdisciplinary Collaboration: Encouraging more interdisciplinary research and collaboration with other fields, such as public health policy or social sciences, could broaden the scope and applicability of her research findings to address community health issues more comprehensively.

    Education 🎓📖

    Dr. Panch earned her MBBS from Bangalore Medical College and Research Institute in India. She furthered her education with a Master’s in Public Health (Epidemiology and Biostatistics) from the University of Minnesota. Her postdoctoral training includes a residency in Internal Medicine at Georgetown University Hospital, followed by a Clinical Fellowship in Transfusion Medicine at the National Institutes of Health, where she also completed a Post-doctoral Research Fellowship in Molecular Hematopoiesis under the mentorship of Dr. Cynthia E. Dunbar.

    Experience 🏥👩‍⚕️

    Dr. Panch has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor at the University of Washington and Medical Director of Transfusion at Fred Hutchinson Cancer Center. Her previous roles include Assistant Research Physician at the NIH Clinical Center and Medical Director at the Center for Cellular Engineering. She has also served as an Attending Physician at NHLBI, NIH, and INOVA SCHAR Cancer Institute, contributing to both clinical practice and research.

    Research Interests 🔬🧬

    Dr. Panch’s research interests are deeply rooted in hematology and transfusion medicine. She focuses on improving hematopoietic progenitor cell mobilization, understanding the impact of manufacturing-related parameters on CAR T-cell product quality, and exploring the safety and efficacy of various treatments for hematologic conditions. Her work aims to enhance patient outcomes through innovative therapeutic approaches and clinical trials.

    Awards 🏆🎖️

    Dr. Panch has received numerous awards and grants throughout her career, including the National Blood Foundation Early Career Award and the NIH Clinical Center Research Award for Staff Clinicians Program. She has been recognized for her contributions to hematology and transfusion medicine, reflecting her dedication to advancing medical research and patient care.

    Publications 📚🖇️